Top Markets
Coin of the day
Eli Lilly Eli Lilly

Eli Lilly

LLY
Kedudukan dalam Saham #15
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals... Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, Trajenta, and Trulicity for type 2 diabetes. The company provides Alimta for non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma; Cyramza for metastatic gastric cancer, gastro-esophageal junction adenocarcinoma, metastatic NSCLC, metastatic colorectal cancer, and hepatocellular carcinoma; Erbitux for colorectal cancers, and various head and neck cancers; Retevmo for metastatic NSCLC, medullary thyroid cancer, and thyroid cancer; Tyvyt for relapsed or refractory classic Hodgkin's lymph and non-squamous NSCLC; and Verzenio for HR+, HER2- metastatic breast cancer, node positive, and early breast cancer. It offers Olumiant for rheumatoid arthritis; and Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis. The company offers Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Emgality for migraine prevention and episodic cluster headache; and Zyprexa for schizophrenia, bipolar I disorder, and bipolar maintenance. Its Bamlanivimab and etesevimab, and Bebtelovimab for COVID-19; Cialis for erectile dysfunction and benign prostatic hyperplasia; and Forteo for osteoporosis. The company has collaborations with Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; AbCellera Biologics Inc.; Junshi Biosciences; Regor Therapeutics Group; Lycia Therapeutics, Inc.; Kumquat Biosciences Inc.; Entos Pharmaceuticals Inc.; and Foghorn Therapeutics Inc. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana.
Harga Saham
$910.55
Modal Pasaran
$860.30B
Perubahan (1 hari)
0.44%
Perubahan (1 tahun)
5.28%
Negara
US
Perdagangan Eli Lilly (LLY)

Kategori

EPS untuk Eli Lilly (LLY)
EPS setakat December 2025 TTM: $23.00
Menurut laporan kewangan terkini dan harga saham Eli Lilly, EPS semasa syarikat (TTM) adalah $23.00. Pada akhir tahun 2024, syarikat mempunyai EPS sebanyak $11.76 penurunan berbanding EPS tahun 2023 iaitu $5.83.
Sejarah EPS untuk Eli Lilly dari 2000 hingga 2026
EPS pada akhir setiap tahun
Tahun EPS Ubah
2026 (TTM) $23.00 0.00%
2025 $23.00 95.58%
2024 $11.76 101.72%
2023 $5.83 -11.26%
2022 $6.57 12.31%
2021 $5.85 -9.58%
2020 $6.47 -25.55%
2019 $8.69 176.75%
2018 $3.14 -1,752.63%
2017 $-0.19 -107.63%
2016 $2.49 14.22%
2015 $2.18 1.40%
2014 $2.15 -48.69%
2013 $4.19 17.37%
2012 $3.57 -8.46%
2011 $3.90 -14.85%
2010 $4.58 16.24%
2009 $3.94 -308.47%
2008 $-1.89 -169.74%
2007 $2.71 10.61%
2006 $2.45 34.62%
2005 $1.82 8.98%
2004 $1.67 -29.83%
2003 $2.38 -5.18%
2002 $2.51 -2.71%
2001 $2.58 -8.83%
2000 $2.83 0.00%
EPS untuk syarikat atau pesaing yang serupa
Syarikat EPS Perbezaan EPS Negara
$13.20 -42.61%
GB
$11.10 -51.74%
US
$2.37 -89.70%
US
$7.20 -68.70%
CH
$7.30 -68.26%
US